BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26509894)

  • 1. A Survey on Use of Rapid Tests and Tuberculosis Diagnostic Practices by Primary Health Care Providers in South Africa: Implications for the Development of New Point-of-Care Tests.
    Davids M; Dheda K; Pant Pai N; Cogill D; Pai M; Engel N
    PLoS One; 2015; 10(10):e0141453. PubMed ID: 26509894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Rapid, Point-of-Care Assays by Private Practitioners in Chennai, India: Priorities for Tuberculosis Diagnostic Testing.
    Bronner Murrison L; Ananthakrishnan R; Sukumar S; Augustine S; Krishnan N; Pai M; Dowdy DW
    PLoS One; 2016; 11(6):e0155775. PubMed ID: 27304061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Before Xpert I only had my expertise": A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities.
    McDowell A; Raizada N; Khaparde SD; Rao R; Sarin S; Kalra A; Salhotra VS; Nair SA; Boehme C; Denkinger CM
    PLoS One; 2018; 13(3):e0193656. PubMed ID: 29547642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.
    Lee DJ; Kumarasamy N; Resch SC; Sivaramakrishnan GN; Mayer KH; Tripathy S; Paltiel AD; Freedberg KA; Reddy KP
    PLoS One; 2019; 14(7):e0218890. PubMed ID: 31265470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.
    Lawn SD; Kerkhoff AD; Burton R; Schutz C; Boulle A; Vogt M; Gupta-Wright A; Nicol MP; Meintjes G
    BMC Med; 2017 Mar; 15(1):67. PubMed ID: 28320384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinic flow for STI, HIV, and TB patients in an urban infectious disease clinic offering point-of-care testing services in Durban, South Africa.
    Stime KJ; Garrett N; Sookrajh Y; Dorward J; Dlamini N; Olowolagba A; Sharma M; Barnabas RV; Drain PK
    BMC Health Serv Res; 2018 May; 18(1):363. PubMed ID: 29751798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating Xpert MTB/RIF for TB diagnosis in the private sector: evidence from large-scale pilots in Patna and Mumbai, India.
    Deo S; Jindal P; Papineni S
    BMC Infect Dis; 2021 Jan; 21(1):123. PubMed ID: 33509114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level.
    Clouse K; Page-Shipp L; Dansey H; Moatlhodi B; Scott L; Bassett J; Stevens W; Sanne I; Van Rie A
    S Afr Med J; 2012 Sep; 102(10):805-7. PubMed ID: 23034211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking private, for-profit providers to public sector services for HIV and tuberculosis co-infected patients: A systematic review.
    Hudson M; Rutherford GW; Weiser S; Fair E
    PLoS One; 2018; 13(4):e0194960. PubMed ID: 29634772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients' experiences in the era of rapid molecular diagnostic tests.
    Naidoo P; van Niekerk M; du Toit E; Beyers N; Leon N
    BMC Health Serv Res; 2015 Oct; 15():488. PubMed ID: 26511931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.
    Engel N; Ochodo EA; Karanja PW; Schmidt BM; Janssen R; Steingart KR; Oliver S
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD014877. PubMed ID: 35470432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of care for tuberculosis and HIV in the private health sector: a cross-sectional, standardised patient study in South Africa.
    Boffa J; Moyo S; Chikovore J; Salomon A; Daniels B; Kwan AT; Pai M; Daftary A
    BMJ Glob Health; 2021 May; 6(5):. PubMed ID: 33990360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalysing progressive uptake of newer diagnostics by health care providers through outreach and education in four major cities of India.
    Raizada N; Khaparde SD; Swaminathan S; Sarin S; Salhotra VS; Kalra A; Khanna A; Chopra KK; Hanif M; Umadevi KR; Hissar S; Nair SA; Prakash CHS; Saha BK; Rao R; Denkinger C; Boehme C
    PLoS One; 2018; 13(3):e0193341. PubMed ID: 29509803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operational assessment of point-of-care diagnostics in rural primary healthcare clinics of KwaZulu-Natal, South Africa: a cross-sectional survey.
    Mashamba-Thompson TP; Sartorius B; Drain PK
    BMC Health Serv Res; 2018 May; 18(1):380. PubMed ID: 29843711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa.
    Lawn SD; Kerkhoff AD; Burton R; Schutz C; van Wyk G; Vogt M; Pahlana P; Nicol MP; Meintjes G
    BMC Med; 2015 Aug; 13():192. PubMed ID: 26275908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upfront Xpert MTB/RIF for diagnosis of pediatric TB-Does it work? Experience from India.
    Kalra A; Parija D; Raizada N; Sachdeva KS; Rao R; Swaminathan S; Khanna A; Chopra KK; Hanif M; Singh V; Umadevi KR; Sheladia KN; Rao R; Vasundhara N; S A; A R N; Azeem A; Chhajlani V; Khurana J; Das NJ; Choudhury B; Nair SA; Mall S; Sen R; Chadha SS; Denkinger CM; Boehme C; Sarin S
    PLoS One; 2020; 15(8):e0236057. PubMed ID: 32756559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing tuberculosis management under public and private healthcare providers: Victoria, Australia, 2002-2015.
    Dale KD; Tay EL; Trauer JM; Trevan PG; Denholm JT
    BMC Infect Dis; 2017 May; 17(1):324. PubMed ID: 28468641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation.
    Raizada N; Khaparde SD; Rao R; Kalra A; Sarin S; Salhotra VS; Swaminathan S; Khanna A; Chopra KK; Hanif M; Singh V; Umadevi KR; Nair SA; Huddart S; Tripathi R; Surya Prakash CH; Saha BK; Denkinger CM; Boehme C
    PLoS One; 2018; 13(8):e0202085. PubMed ID: 30161142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.